×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

South America Heart Pump Devices Market

ID: MRFR/HC/52756-HCR
200 Pages
Garvit Vyas
October 2025

South America Heart Pump Devices Market Research Report: By Product (Ventricular Assist Devices, Left Ventricular Assist Devices, Right Ventricular Assist Devices, Bi- Ventricular Assist Devices, Percutaneous Ventricular Assist Devices, Transcutaneous Ventricular Assist Devices, Intra-Aortic Balloon Pumps, Total Artificial Heart), By Device Type (Implantable Heart Pump Devices, Extracorporeal Heart Pump Devices), By Therapy (Bridge-to-candidacy (BTC), Bridge-to-transplant (BTC), Destination Therapy (DT), Others), By End-User (Hospitals &... read more

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

South America Heart Pump Devices Market Infographic
Purchase Options

South America Heart Pump Devices Market Summary

As per MRFR analysis, the South America heart pump-devices market size was estimated at 74.12 $ Million in 2024. The South America heart pump-devices market is projected to grow from 90.05 $ Million in 2025 to 631.44 $ Million by 2035, exhibiting a compound annual growth rate (CAGR) of 21.5% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The South America heart pump-devices market is experiencing robust growth driven by technological advancements and increasing healthcare investments.

  • Brazil remains the largest market for heart pump-devices, reflecting a strong demand for advanced cardiovascular solutions.
  • Mexico is emerging as the fastest-growing region, indicating a rising adoption of innovative heart pump technologies.
  • Technological advancements and regulatory changes are shaping the market landscape, enhancing product offerings and accessibility.
  • The increasing prevalence of cardiovascular diseases and growing aging population are key drivers propelling market expansion.

Market Size & Forecast

2024 Market Size 74.12 (USD Million)
2035 Market Size 631.44 (USD Million)

Major Players

Abbott (US), Medtronic (US), Boston Scientific (US), Terumo (JP), Cleveland Heart (US), CardiacAssist (US), Syncardia (US), Getinge (SE), LivaNova (GB)

South America Heart Pump Devices Market Trends

The heart pump-devices market is currently experiencing notable growth in South America, driven by an increasing prevalence of cardiovascular diseases and a rising aging population. This region is witnessing advancements in technology, leading to the development of innovative devices that enhance patient outcomes. Furthermore, healthcare infrastructure improvements and increased access to medical services are contributing to the market's expansion. The demand for heart pump devices is likely to rise as healthcare providers focus on offering better treatment options for patients with heart conditions. In addition, the regulatory environment in South America appears to be evolving, with governments emphasizing the importance of medical device approvals and quality standards. This shift may facilitate the entry of new products into the market, thereby enhancing competition. Moreover, partnerships between local manufacturers and international companies could lead to the introduction of advanced technologies tailored to meet regional needs. Overall, the heart pump-devices market in South America seems poised for continued growth, driven by technological advancements and an increasing focus on cardiovascular health.

Technological Advancements

The heart pump-devices market is witnessing rapid technological advancements, with innovations such as miniaturization and improved biocompatibility. These developments enhance device performance and patient comfort, making treatments more effective.

Regulatory Changes

Recent regulatory changes in South America are streamlining the approval process for heart pump devices. This trend may encourage manufacturers to introduce new products, thereby increasing market competition and improving patient access.

Rising Healthcare Investments

There is a growing trend of increased investments in healthcare infrastructure across South America. This investment is likely to enhance the availability of heart pump devices, improving treatment options for patients with cardiovascular diseases.

South America Heart Pump Devices Market Drivers

Growing Aging Population

The demographic shift towards an aging population in South America is a crucial driver for the heart pump-devices market. As individuals age, the risk of developing heart-related ailments increases, leading to a higher demand for effective treatment solutions. Current projections indicate that by 2030, the population aged 65 and older in South America will exceed 10% of the total population. This demographic trend is likely to result in a surge in heart failure cases, necessitating the use of heart pump devices. Healthcare providers are increasingly focusing on geriatric care, which includes the integration of heart pump technologies to manage chronic conditions. Consequently, the heart pump-devices market is poised for growth as it adapts to meet the needs of this expanding patient demographic.

Rising Healthcare Expenditure

In South America, the increase in healthcare expenditure is a significant driver for the heart pump-devices market. Governments and private sectors are investing more in healthcare infrastructure, which includes the procurement of advanced medical devices. Recent data suggests that healthcare spending in the region has risen by approximately 5% annually, reflecting a commitment to improving health outcomes. This financial support enables hospitals and clinics to acquire state-of-the-art heart pump devices, enhancing their capacity to treat patients with severe cardiovascular conditions. As healthcare systems evolve and expand, the heart pump-devices market is likely to benefit from increased accessibility and availability of these critical technologies, ultimately leading to improved patient care.

Advancements in Medical Technology

Technological innovations in the medical field are significantly influencing the heart pump-devices market in South America. The development of minimally invasive procedures and advanced materials has enhanced the efficacy and safety of heart pump devices. For instance, the introduction of wearable heart pumps and implantable devices has revolutionized treatment options for patients with severe heart conditions. These advancements not only improve patient quality of life but also reduce hospital stays and associated costs. Market data indicates that the heart pump-devices market is projected to grow at a CAGR of approximately 8% over the next five years, driven by these technological advancements. As healthcare systems in South America continue to adopt these innovations, the demand for sophisticated heart pump devices is expected to rise, further solidifying their role in cardiovascular care.

Enhanced Patient Awareness and Education

The growing awareness and education regarding heart health among the South American population are driving the heart pump-devices market. Public health campaigns and educational initiatives have increased knowledge about cardiovascular diseases and the importance of early intervention. As patients become more informed about treatment options, including heart pump devices, they are more likely to seek medical advice and treatment. This shift in patient behavior is expected to lead to higher demand for heart pump technologies. Additionally, healthcare providers are increasingly focusing on patient-centered care, which emphasizes the importance of educating patients about their conditions and available treatments. This trend may contribute to a more proactive approach to managing heart health, further stimulating the heart pump-devices market.

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases in South America is a primary driver for the heart pump-devices market. According to health statistics, cardiovascular diseases account for a significant portion of mortality in the region, with estimates suggesting that they contribute to over 30% of all deaths. This alarming trend necessitates advanced medical interventions, including heart pump devices, to manage heart failure and other related conditions. As healthcare providers seek to improve patient outcomes, the demand for innovative heart pump technologies is likely to increase. Furthermore, the growing awareness of heart health among the population may lead to earlier diagnoses and treatments, further propelling the heart pump-devices market. The combination of these factors indicates a robust growth trajectory for heart pump devices in South America.

Market Segment Insights

By Product: Left Ventricular Assist Devices (Largest) vs. Total Artificial Heart (Fastest-Growing)

In the South America heart pump-devices market, Left Ventricular Assist Devices (LVADs) hold the largest market share due to their wide applicability in patients suffering from severe heart failure. Following LVADs, Right Ventricular Assist Devices (RVADs) and Intra-Aortic Balloon Pumps (IABPs) also command significant shares, driven by their effectiveness in providing temporary support during critical phases. Other emerging devices, such as Bi-Ventricular Assist Devices and Percutaneous Ventricular Assist Devices, contribute to the market but remain comparatively smaller in share. The growth trends indicate a rising demand for advanced cardiac support technologies as more patients are diagnosed with heart-related ailments. The increasing prevalence of cardiovascular diseases, coupled with technological advancements in pump devices, fuels the expansion of this segment. Factors like an aging population and improved healthcare infrastructure are also instrumental in accelerating the adoption of heart pump devices, particularly the Total Artificial Heart, which is recognized as the fastest-growing segment due to its innovative features.

Ventricular Assist Devices (Dominant) vs. Percutaneous Ventricular Assist Devices (Emerging)

Ventricular assist devices, particularly Left and Right Ventricular Assist Devices, are dominant in this market owing to their robust performance in supporting heart function for patients awaiting transplants or recovering from heart surgery. These devices provide significant long-term support and are increasingly recognized for their ability to improve patient quality of life. In contrast, Percutaneous Ventricular Assist Devices represent an emerging category that offers temporary support during critical phases of heart failure and are more accessible due to their minimally invasive insertion procedures. As healthcare providers look for rapid solutions, especially in emergency settings, the adoption of these percutaneous devices is anticipated to grow, complementing the established presence of more permanent assist devices.

By Device Type: Implantable heart pump devices (Largest) vs. Extracorporeal heart pump devices (Fastest-Growing)

The South America heart pump-devices market showcases a distinct preference for implantable heart pump devices, which hold the largest market share. These devices are increasingly favored by healthcare providers due to their advantages in providing continuous and reliable cardiac support for patients. Meanwhile, extracorporeal heart pump devices are gaining traction as an innovative solution, supporting patients on a temporary basis during critical interventions. Growth trends indicate a shift towards more advanced technologies in heart pump devices within South America. Factors driving this growth include rising incidences of heart-related ailments, increasing healthcare investments, and a growing awareness among patients regarding treatment options. As a result, the demand for both implantable and extracorporeal devices is expected to increase, with extracorporeal devices emerging as a key player in innovative therapeutic solutions.

Device Type: Implantable heart pump devices (Dominant) vs. Extracorporeal heart pump devices (Emerging)

Implantable heart pump devices are characterized by their long-term viability and are widely used for patients suffering from severe heart failure. Their integration into the patient's body allows for improved quality of life and enhanced mobility. These devices dominate the market due to their established clinical outcomes and robust manufacturer support. Conversely, extracorporeal heart pump devices represent an emerging category focused on short-term use in critical care settings. Their significance is rising as they are used in surgeries and during critical management of patients, giving them a competitive edge for advancements in technology and versatility in diverse medical scenarios.

By Therapy: Bridge-to-transplant (Largest) vs. Destination therapy (Fastest-Growing)

In the South America heart pump-devices market, the distribution of market share among the therapy segment values showcases a clear leader: Bridge-to-transplant (BTC), which dominates this space, while Destination therapy (DT) emerges as a rapidly growing alternative. The Others category holds a smaller share but remains relevant in the overall landscape. The growth dynamics of these therapies indicate a shift towards more innovative and effective solutions, addressing critical patient needs. The growth trends within this segment are largely driven by factors such as increasing prevalence of advanced heart failure and the rising demand for life-saving technologies. The expansion of healthcare infrastructure and the introduction of several new products are propelling Destination therapy into a more prominent position among healthcare providers. Additionally, collaboration between manufacturers and healthcare facilities is enhancing accessibility and driving adoption rates for these therapies.

Bridge-to-candidacy (Dominant) vs. Others (Emerging)

Bridge-to-candidacy (BTC) has established itself as a dominant player in the heart pump therapy segment, primarily due to its effectiveness in evaluating patients for potential transplant eligibility. This therapy type typically offers a temporary solution, ensuring patients receive necessary support while awaiting a transplant. In contrast, the Others segment, while not as prominent, serves diverse needs with specialized devices that may cater to unique patient conditions. As healthcare professionals emphasize personalized treatment plans, the Emerging category is witnessing increased interest, highlighting its potential for growth in niche applications as distinct patient groups seek tailored cardiac support solutions.

By End-User: Hospitals & Clinics (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

The market distribution among end-user segments shows that Hospitals & Clinics dominate the landscape, accounting for a significant portion of the overall demand for heart pump devices. Ambulatory surgical centers, while smaller in share, are rapidly gaining traction due to their growing adoption of advanced medical technologies and shift towards outpatient care settings. Research institutes and other facilities also contribute to the market but represent a fraction of the overall segment distribution. In terms of growth trends, Ambulatory surgical centers are emerging as the fastest-growing segment, driven by increasing healthcare expenditure and a preference for minimally invasive procedures among patients. Hospitals & Clinics are expected to maintain their dominant position, supported by their established infrastructure and the rising prevalence of cardiovascular diseases. Research institutes continue to play a crucial role in innovation, although their growth is more stable compared to the explosive growth observed in ambulatory surgical centers.

Hospitals & Clinics (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals & Clinics represent the dominant end-user segment for heart pump devices, characterized by their extensive facilities and advanced treatment capabilities. These institutions are equipped to manage complex cardiac cases, facilitating a steady demand for various heart pump devices. On the other hand, Ambulatory Surgical Centers are considered an emerging segment, reflecting a shift in healthcare dynamics towards outpatient services. Their growth is propelled by advancements in surgical techniques and patient preferences for quicker recovery times. As healthcare systems evolve, the role of these centers is becoming increasingly vital, with a focus on delivering specialized care in a more efficient manner.

Get more detailed insights about South America Heart Pump Devices Market

Regional Insights

Brazil : Strong Demand and Innovation Drive Growth

Brazil holds a commanding 30.0% market share in the South American heart pump devices market, valued at approximately $300 million. Key growth drivers include an aging population, rising cardiovascular diseases, and increased healthcare spending. Government initiatives, such as the National Health System's focus on advanced medical technologies, further stimulate demand. The country's robust healthcare infrastructure and industrial development also support market expansion.

Mexico : Growing Demand for Advanced Solutions

Mexico accounts for 15.0% of the South American heart pump devices market, valued at around $150 million. The market is driven by increasing awareness of cardiovascular health and government initiatives promoting healthcare access. Demand trends indicate a shift towards minimally invasive procedures, supported by regulatory policies that encourage innovation. The growing middle class is also contributing to higher healthcare expenditure.

Argentina : Investment in Healthcare Infrastructure

Argentina holds a 20.0% share of the heart pump devices market in South America, valued at approximately $200 million. Key growth drivers include government investments in healthcare infrastructure and rising incidences of heart diseases. Regulatory frameworks are becoming more favorable, promoting the adoption of advanced medical technologies. The demand for heart pumps is also increasing due to a growing elderly population.

Rest of South America : Diverse Needs Across Sub-regions

The Rest of South America represents 9.12% of the heart pump devices market, valued at about $90 million. This sub-region faces unique challenges, including varying healthcare regulations and economic disparities. However, there is a growing demand for heart pump devices driven by increasing awareness of cardiovascular health. Local governments are beginning to invest in healthcare initiatives, albeit at a slower pace than larger markets.

South America Heart Pump Devices Market Regional Image

Key Players and Competitive Insights

The heart pump-devices market in South America is characterized by a dynamic competitive landscape, driven by technological advancements and increasing demand for innovative cardiac solutions. Key players such as Abbott (US), Medtronic (US), and Boston Scientific (US) are at the forefront, each adopting distinct strategies to enhance their market presence. Abbott (US) focuses on innovation, particularly in developing next-generation heart pump technologies, while Medtronic (US) emphasizes strategic partnerships to expand its product offerings. Boston Scientific (US) is actively pursuing regional expansion, aiming to penetrate emerging markets within South America, thereby shaping a competitive environment that is increasingly collaborative yet fiercely competitive.

The business tactics employed by these companies reflect a concerted effort to optimize operations and enhance market responsiveness. Localizing manufacturing has become a prevalent strategy, allowing companies to reduce costs and improve supply chain efficiency. The market structure appears moderately fragmented, with several players vying for market share, yet the collective influence of major companies like Abbott, Medtronic, and Boston Scientific creates a robust competitive framework that drives innovation and market growth.

In October 2025, Abbott (US) announced the launch of a new heart pump device designed specifically for patients with advanced heart failure, showcasing its commitment to innovation. This strategic move not only reinforces Abbott's position as a leader in the market but also addresses the growing need for specialized cardiac solutions in South America. The introduction of this device is likely to enhance patient outcomes and solidify Abbott's competitive edge.

In September 2025, Medtronic (US) entered into a partnership with a local South American healthcare provider to enhance distribution channels for its heart pump devices. This collaboration is strategically significant as it allows Medtronic to leverage local expertise and improve access to its products, thereby increasing market penetration. Such partnerships are indicative of a broader trend towards localized strategies that cater to regional healthcare needs.

In August 2025, Boston Scientific (US) expanded its manufacturing capabilities in Brazil, investing $50 million to enhance production efficiency for its heart pump devices. This investment underscores Boston Scientific's commitment to regional growth and its strategy to meet the increasing demand for cardiac devices in South America. By bolstering its manufacturing presence, the company positions itself to respond swiftly to market changes and customer needs.

As of November 2025, the competitive trends in the heart pump-devices market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI) into product development. Strategic alliances are becoming more prevalent, facilitating knowledge sharing and resource optimization among key players. Looking ahead, competitive differentiation is likely to evolve, shifting from traditional price-based competition to a focus on innovation, advanced technology, and reliable supply chains. This transition suggests that companies that prioritize these aspects will be better positioned to thrive in an increasingly complex market.

Key Companies in the South America Heart Pump Devices Market market include

Industry Developments

The South America Heart Pump Devices Market has seen significant developments recently, driven by advancements in technology and increasing incidences of cardiovascular diseases. Medtronic has expanded its product offerings in Brazil, particularly focusing on advanced heart pump technologies, enhancing patient outcomes.

Tandem Diabetes has made strides in innovative insulin delivery, which could indirectly support heart health management among diabetic patients in the region. LivaNova and Abbot Laboratories are making headlines with their ongoing research into ventricular assist devices aimed at addressing heart failure issues prevalent in South America.

In terms of mergers and acquisitions, there have been no recent transactions specifically involving the companies in focus within South America in the last few months. However, the overall market valuation of heart pump devices has exhibited considerable growth, reflecting a rising demand due to an aging population and increased awareness of cardiovascular health.

The Brazilian government has also been promoting health initiatives that emphasize advanced medical technology, which includes heart pump devices. Over the past few years, significant advancements in clinical trials and regulatory approvals have catalyzed the market, with noteworthy developments reported in 2021 that continue to impact the landscape today.

Future Outlook

South America Heart Pump Devices Market Future Outlook

The Heart Pump Devices Market is projected to grow at a 21.5% CAGR from 2024 to 2035, driven by technological advancements, increasing cardiovascular diseases, and rising healthcare expenditure.

New opportunities lie in:

  • Development of portable heart pump devices for home care settings.
  • Expansion of telehealth services for remote patient monitoring.
  • Strategic partnerships with local hospitals for device trials and adoption.

By 2035, the heart pump-devices market is expected to achieve substantial growth and innovation.

Market Segmentation

South America Heart Pump Devices Market Product Outlook

  • Ventricular assist devices
  • Left ventricular assist devices
  • Right ventricular assist devices
  • Bi-ventricular assist devices
  • Percutaneous ventricular assist devices
  • Transcutaneous ventricular assist devices
  • Intra-Aortic balloon pumps
  • Total artificial heart

South America Heart Pump Devices Market Therapy Outlook

  • Bridge-to-candidacy (BTC)
  • Bridge-to-transplant (BTC)
  • Destination therapy (DT)
  • Others

South America Heart Pump Devices Market End-User Outlook

  • Hospitals & Clinics
  • Ambulatory surgical centers
  • Research institutes
  • Others

South America Heart Pump Devices Market Device Type Outlook

  • Implantable heart pump devices
  • Extracorporeal heart pump devices

Report Scope

MARKET SIZE 202474.12(USD Million)
MARKET SIZE 202590.05(USD Million)
MARKET SIZE 2035631.44(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)21.5% (2024 - 2035)
REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR2024
Market Forecast Period2025 - 2035
Historical Data2019 - 2024
Market Forecast UnitsUSD Million
Key Companies Profiled["Abbott (US)", "Medtronic (US)", "Boston Scientific (US)", "Terumo (JP)", "Cleveland Heart (US)", "CardiacAssist (US)", "Syncardia (US)", "Getinge (SE)", "LivaNova (GB)"]
Segments CoveredProduct, Device Type, Therapy, End-User
Key Market OpportunitiesEmerging technologies in heart pump-devices market enhance patient outcomes and drive demand in South America.
Key Market DynamicsRising demand for innovative heart pump devices driven by regulatory support and evolving patient care standards in South America.
Countries CoveredBrazil, Mexico, Argentina, Rest of South America

Leave a Comment

FAQs

What is the expected market size of the South America Heart Pump Devices Market in 2024?

The market size of the South America Heart Pump Devices Market is expected to be valued at 59.2 million USD in 2024.

What will be the projected market size in 2035?

By 2035, the South America Heart Pump Devices Market is expected to reach a valuation of 448.03 million USD.

What is the expected CAGR for the South America Heart Pump Devices Market from 2025 to 2035?

The expected CAGR for the South America Heart Pump Devices Market from 2025 to 2035 is 20.201%.

Which country holds the largest market share in the South America Heart Pump Devices Market?

Brazil is anticipated to hold the largest market share, with a value of 20.5 million USD in 2024 and expected to grow to 150.07 million USD by 2035.

What are the key players in the South America Heart Pump Devices Market?

Major players in the market include Medtronic, Abbott Laboratories, and Boston Scientific among others.

How much will the Left Ventricular Assist Devices segment be valued in 2035?

The Left Ventricular Assist Devices segment is projected to be valued at 150.0 million USD in 2035.

What is the expected market value for Right Ventricular Assist Devices in 2024?

The Right Ventricular Assist Devices segment is expected to be valued at 15.0 million USD in 2024.

What is the estimated market growth for Argentina by 2035?

Argentina is expected to see its Heart Pump Devices Market grow to 75.21 million USD by 2035.

Which product segment is expected to have the highest growth during the forecast period?

The Left Ventricular Assist Devices segment is anticipated to experience significant growth with a valuation of 150.0 million USD in 2035.

What is the market value for Bi-Ventricular Assist Devices in 2024 and 2035?

The Bi-Ventricular Assist Devices segment is expected to be valued at 5.0 million USD in 2024 and 40.0 million USD in 2035.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions